Murine stem cell factor polypeptides, compositions, and methods of use
AssigneeElixr Ltd
InventorsYaron FUCHS, Matan YAMPOLSKY, Roi ANKAWA, Noa JOSEPH, Guy MANN, Ronen WEISS, Nimrod KRUPNIK, Roy HESSEL
Life of this patent
Estimating the term…
Loading patent…
AssigneeElixr Ltd
InventorsYaron FUCHS, Matan YAMPOLSKY, Roi ANKAWA, Noa JOSEPH, Guy MANN, Ronen WEISS, Nimrod KRUPNIK, Roy HESSEL
Estimating the term…
Provided herein are murine stem cell factor (mSCF) polypeptides, as well as compositions comprising the same, and methods of using the same. In some embodiments, the mSCF polypeptides are for use in treating one or more conditions in a human subject. Such conditions to be treated may include, but are not limited to, melanocyte dysfunction or deficiency, and processes associated with the same. The present disclosure also provides the use of such mSCF polypeptides for the treatment of hair loss and/or hair whitening.
A method of treating a condition of a human subject, the method comprising administering to the human subject a composition comprising one or more of a murine Stem Cell Factor (mSCF) polypeptide;
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A composition comprising an mSCF polypeptide, wherein (i) the mSCF polypeptide is joined to a cell-penetrating peptide, or (ii) the mSCF polypeptide comprises an N-terminal truncation of at least 10 amino acids as compared to SEQ ID NO:
-57. (canceled)
Dependencies are inferred from the claim text.